These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8274410)
1. Involvement of GABAB receptors in the regulation of the hypothalamo-pituitary-adrenocortical (HPA) axis in rats. Häusler A; Monnet G; Peter O J Steroid Biochem Mol Biol; 1993 Dec; 46(6):767-71. PubMed ID: 8274410 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase and the hypothalamic-pituitary-adrenal axis of the rat. Celichowski P; Jopek K; Milecka P; Szyszka M; Tyczewska M; Malendowicz LK; Ruciński M Mol Med Rep; 2018 Apr; 17(4):6163-6173. PubMed ID: 29436637 [TBL] [Abstract][Full Text] [Related]
3. Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat. Suemaru S; Dallman MF; Darlington DN; Cascio CS; Shinsako J Neuroendocrinology; 1989 Feb; 49(2):181-90. PubMed ID: 2542829 [TBL] [Abstract][Full Text] [Related]
4. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. van Haarst AD; Oitzl MS; Workel JO; de Kloet ER Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366 [TBL] [Abstract][Full Text] [Related]
5. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the 2-deoxyglucose effect on the adrenocortical axis. Weidenfeld J; Corcos AP; Wohlman A; Feldman S Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline. Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165 [TBL] [Abstract][Full Text] [Related]
8. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244 [TBL] [Abstract][Full Text] [Related]
9. GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. Waldmeier PC; Wicki P; Feldtrauer JJ; Mickel SJ; Bittiger H; Baumann PA Br J Pharmacol; 1994 Dec; 113(4):1515-21. PubMed ID: 7889310 [TBL] [Abstract][Full Text] [Related]
10. Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle. Weidenfeld J; Itzik A; Feldman S Brain Res; 1997 Apr; 754(1-2):187-94. PubMed ID: 9134975 [TBL] [Abstract][Full Text] [Related]
11. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons. Obrietan K; van den Pol AN J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro. Bon C; Galvan M Br J Pharmacol; 1996 Jun; 118(4):961-7. PubMed ID: 8799569 [TBL] [Abstract][Full Text] [Related]
13. The role of lipocortin 1 (LC1) in the steroid feedback control of hypothalamo-pituitary-adrenocortical function. In vivo studies. Taylor AD; Loxley HD; Flower RJ; Buckingham JC Ann N Y Acad Sci; 1994 Nov; 746():446-8. PubMed ID: 7825911 [No Abstract] [Full Text] [Related]
14. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats. Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress. Gadek-Michalska A; Bugajski J J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770 [TBL] [Abstract][Full Text] [Related]
16. Neuromedin-U stimulates enucleation-induced adrenocortical regeneration in the rat. Trejter M; Neri G; Rucinski M; Majchrzak M; Nussdorfer GG; Malendowicz LK Int J Mol Med; 2008 Jun; 21(6):683-7. PubMed ID: 18506360 [TBL] [Abstract][Full Text] [Related]
17. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity. Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902 [TBL] [Abstract][Full Text] [Related]
19. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat. Buckingham JC; Cooper TA Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154 [TBL] [Abstract][Full Text] [Related]
20. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress. Bugajski J; Gadek-Michalska A; Bugajski AJ J Physiol Pharmacol; 2002 Sep; 53(3):453-62. PubMed ID: 12369741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]